Postmarket Outcomes Study for Evaluation of the Superion™ Spacer

NCT04563793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2025-01-13

Study results available
· View outcomes & findings →

Summary

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Conditions

  • Lumbar Spinal Stenosis

Interventions

DEVICE

Superion™ IDS

All patients to receive IDS for the treatment of moderate Lumbar Spinal Stenosis symptoms.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Natalie Bloom Lyons · Boston Scientific Corporation

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2023-03-20
Completion
2023-03-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563793 on ClinicalTrials.gov